[go: up one dir, main page]

WO2007113598A3 - Compositions vaccinales - Google Patents

Compositions vaccinales Download PDF

Info

Publication number
WO2007113598A3
WO2007113598A3 PCT/GB2007/050181 GB2007050181W WO2007113598A3 WO 2007113598 A3 WO2007113598 A3 WO 2007113598A3 GB 2007050181 W GB2007050181 W GB 2007050181W WO 2007113598 A3 WO2007113598 A3 WO 2007113598A3
Authority
WO
WIPO (PCT)
Prior art keywords
pneumococcal
6bpp
pneumococcal infection
vaccine
peptide mimetope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2007/050181
Other languages
English (en)
Other versions
WO2007113598A2 (fr
Inventor
Peter Andrew
Claire Mary Smith
Carla Lopasso
Helen Baxendale
David Goldblatt
Franco Felici
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Leicester
Original Assignee
University of Leicester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Leicester filed Critical University of Leicester
Publication of WO2007113598A2 publication Critical patent/WO2007113598A2/fr
Publication of WO2007113598A3 publication Critical patent/WO2007113598A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne un mimotope peptidique de polysaccharide pneumococcique de sérotype 6B (6BPP) de Streptococcus pneumoniae, éventuellement conjugué à une protéine support, capable de stimuler une réponse immunitaire protectrice contre une infection pneumococcique. L'invention concerne également un anticorps monoclonal (AcM) dirigé contre un polysaccharide pneumococcique 6B et des fragments de liaison à 6BPP correspondants, pouvant conférer une immunité passive contre une infection pneumococcique. Par ailleurs, l'invention concerne des compositions comprenant ce mimotope peptidique, ce conjugué, cet AcM ou un fragment de liaison correspondant. Les peptides mimétiques, leurs conjugués, l'AcM et les fragments de liaison à 6BPP de l'invention sont utilisés comme médicaments et dans la fabrication de médicaments destinés à traiter une infection pneumococcique. L'invention se rapporte en outre à des méthodes de traitement prophylactique ou thérapeutique d'une infection pneumococcique.
PCT/GB2007/050181 2006-04-05 2007-04-05 Compositions vaccinales Ceased WO2007113598A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0606856A GB0606856D0 (en) 2006-04-05 2006-04-05 Vaccine compositions
GB0606856.3 2006-04-05

Publications (2)

Publication Number Publication Date
WO2007113598A2 WO2007113598A2 (fr) 2007-10-11
WO2007113598A3 true WO2007113598A3 (fr) 2007-12-06

Family

ID=36539375

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2007/050181 Ceased WO2007113598A2 (fr) 2006-04-05 2007-04-05 Compositions vaccinales

Country Status (2)

Country Link
GB (1) GB0606856D0 (fr)
WO (1) WO2007113598A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12473351B2 (en) 2014-10-28 2025-11-18 Adma Biomanufacturing, Llc Compositions and methods for the treatment of immunodeficiency

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011660A2 (fr) * 1997-09-04 1999-03-11 Institut Pasteur Polypeptides immunogenes mimant un antigene de surface polysaccharidique d'un micro-organisme pathogene, technique de production de ces polypeptides et utilisation dans des compositions vaccinales
US20040198960A1 (en) * 2001-03-29 2004-10-07 Janoff Edward N Human monoclonal antibodies against capsular polysaccharides of streptococcus pneumoniae

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011660A2 (fr) * 1997-09-04 1999-03-11 Institut Pasteur Polypeptides immunogenes mimant un antigene de surface polysaccharidique d'un micro-organisme pathogene, technique de production de ces polypeptides et utilisation dans des compositions vaccinales
US20040198960A1 (en) * 2001-03-29 2004-10-07 Janoff Edward N Human monoclonal antibodies against capsular polysaccharides of streptococcus pneumoniae

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BAXENDALE H E ET AL: "Correlation of molecular characteristics, isotype, and in vitro functional activity of human antipneumococcal monoclonal antibodies.", INFECTION AND IMMUNITY FEB 2006, vol. 74, no. 2, February 2006 (2006-02-01), pages 1025 - 1031, XP002450971, ISSN: 0019-9567 *
BUCHWALD ULRIKE K ET AL: "A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in mice.", INFECTION AND IMMUNITY JAN 2005, vol. 73, no. 1, January 2005 (2005-01-01), pages 325 - 333, XP002450973, ISSN: 0019-9567 *
JESSUP C F ET AL: "Preparation of human-mouse heterohybridomas against an immunising antigen", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 246, no. 1-2, 1 December 2000 (2000-12-01), pages 187 - 202, XP004220753, ISSN: 0022-1759 *
JONSSON S ET AL: "Vaccination of COPD patients with a pneumococcus type 6B tetanus toxoid conjugate vaccine", EUROPEAN RESPIRATORY JOURNAL, vol. 20, no. 4, October 2002 (2002-10-01), pages 813 - 818, XP002450974, ISSN: 0903-1936 *
LUCAS A H ET AL: "Combinatorial library cloning of human antibodies to Streptococcus pneumoniae capsular polysaccharides: variable region primary structures and evidence for somatic mutation of Fab fragments specific for capsular serotypes 6B, 14, and 23F.", INFECTION AND IMMUNITY FEB 2001, vol. 69, no. 2, February 2001 (2001-02-01), pages 853 - 864, XP002450976, ISSN: 0019-9567 *
SHIN JEON-SOO ET AL: "Peptide mimotopes of pneumococcal capsular polysaccharide of 6B serotype: a peptide mimotope can bind to two unrelated antibodies.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 15 JUN 2002, vol. 168, no. 12, 15 June 2002 (2002-06-15), pages 6273 - 6278, XP002450970, ISSN: 0022-1767 *
SUN Y ET AL: "Repertoire of human antibodies against the polysaccharide capsule of Streptococcus pneumoniae serotype 6B.", INFECTION AND IMMUNITY MAR 1999, vol. 67, no. 3, March 1999 (1999-03-01), pages 1172 - 1179, XP002450975, ISSN: 0019-9567 *
ZHOU JIANHUI ET AL: "Somatic hypermutation and diverse immunoglobulin gene usage in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae Type 6B.", INFECTION AND IMMUNITY JUN 2004, vol. 72, no. 6, June 2004 (2004-06-01), pages 3505 - 3514, XP002450972, ISSN: 0019-9567 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12473351B2 (en) 2014-10-28 2025-11-18 Adma Biomanufacturing, Llc Compositions and methods for the treatment of immunodeficiency

Also Published As

Publication number Publication date
WO2007113598A2 (fr) 2007-10-11
GB0606856D0 (en) 2006-05-17

Similar Documents

Publication Publication Date Title
WO2004080490A3 (fr) Conjugues de proteine-polysaccharide porteuse d'adhesine superficielle staphylococcique pour immunisation contre des infections nosocomiales
WO2000056360A3 (fr) Vaccin
HK1043943A1 (zh) 肺炎链球菌蛋白质和疫苗
WO2009055711A3 (fr) Anticorps de protéine g anti-rsv
WO2006032472A3 (fr) Composition immunogene
WO2007094842A3 (fr) Polypeptides de liaison et leurs utilisations
WO2008146164A3 (fr) Antigènes de pilus de streptococcus pneumoniae
GB0428394D0 (en) Saccharide conjugate vaccines
WO2007106476A3 (fr) Compositions et procédés pour renforcer l'immunogénicité d'antigènes
WO2010141312A3 (fr) Protéines de fusion flagelline et conjugués comprenant des antigènes pneumocoques et leurs procédés d'utilisation
WO2003064473A3 (fr) Fragments fab d'anticorps monoclonaux humains diriges contre la glycoproteine vhc/e2 et possedant une activite de neutralisation in vitro
WO2001081380A3 (fr) Proteine pneumococcique immunogenique et ses compositions de vaccins
WO2006021955A3 (fr) Utilisation d'anticorps monoclonaux bat pour l'immunotherapie
WO2005120557A3 (fr) Inhibition du recepteur proteique stimulant les macrophages (ron)
WO2006042149A3 (fr) Determination et reduction de l'immunoresistance a la therapie de la toxine botulinique a l'aide de peptides de la toxine botulinique de type a
WO2008103845A3 (fr) Anticorps monoclonaux neutralisant les toxines de l'anthrax
WO2008127094A3 (fr) Nouveaux facteurs de virulence de streptococcus pneumoniae
WO2007113598A3 (fr) Compositions vaccinales
WO2009115509A3 (fr) Fragments de protéine antigénique de streptococcus pneumoniae
WO2005120563A3 (fr) Induction d'une reponse immunitaire contre des polysaccharides streptococcus pneumoniae
WO2004041864A3 (fr) Therapie passive par anticorps hyperimmuns utilisee dans le traitement de l'anthrax
WO2007084107A3 (fr) Anticorps monoclonaux neutralisant l’antigene protecteur (ap) du charbon
WO2005007804A3 (fr) Vaccin conjugue contre l'anthrax et anticorps diriges contre des bacilles et des toxines de l'anthrax
WO2004032832A3 (fr) Molecule bispecifique comprenant un anticorps anti cr1 reticule a un fragment d'anticorps a liaison antigenique
WO2020086885A3 (fr) Glycopeptides multivalents qui se lient étroitement à la famille pgt128 d'anticorps monoclonaux se liant aux hydrates de carbone

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07733604

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07733604

Country of ref document: EP

Kind code of ref document: A2